Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jun 4, 2020
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Common Stock
2020-06-02$2.62/sh+33,997$89,072→ 57,997 total
Footnotes (1)
- [F1]Stock granted under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus.